iTeos Therapeutics Stock Quote ITOS - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

11.52

Bid

11.51

Ask

11.53

Volume

322,387

11.26 Day's Range 11.67

8.20 52 Week Range 18.75

Market Cap

420.732M

Previous Close

11.59

Open

11.52

Last Trade

11.5164

Last Trade Time

12:37:33

Financial Volume

$ 3,700,213

VWAP

11.4775

Average Volume (3m)

477,068

Shares Outstanding

36,521,845

Dividend Yield

PE Ratio

-3.72

Earnings Per Share (EPS)

-3.08

Revenue

12.6M

Net Profit

-112.64M

ITeos Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of immuno-oncology therapeutics for patients. Its product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoin... ITeos Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of immuno-oncology therapeutics for patients. Its product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.iteostherapeutics.com

Headquarters

Wilmington, Delaware, USA

Founded

iTeos Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker ITOS. The last closing price for iTeos Therapeutics was $11.59. Over the last year, iTeos Therapeutics shares have traded in a share price range of $ 8.20 to $ 18.75.

iTeos Therapeutics currently has 36,521,845 shares outstanding. The market capitalization of iTeos Therapeutics is $423.29 million. iTeos Therapeutics has a price to earnings ratio (PE ratio) of -3.72.

Form 8-K - Current report

iTeos Announces Clinically Meaningful Objective Response Rate Observed at Every Dose in Follow-up Interim Analysis of GALAXIES Lung-201 Study of Belrestotug + Dostarlimab in First-Line, PD-L1 High Non-Small Cell Lung Cancer Patients

- Clinically meaningful objective response rate (ORR) of 63.3-76.7% observed with belrestotug + dostarlimab combinations, with confirmed ORR (cORR) at ~60% for every dose- >30% cORR difference...

iTeos to Participate in Upcoming Investor Conferences

WATERTOWN, Mass. and GOSSELIES, Belgium, Aug. 28, 2024 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS) (“iTeos”), a clinical-stage biopharmaceutical company pioneering the discovery...

iTeos Therapeutics Announces Late-Breaking Oral Presentation of Phase 2 GALAXIES Lung-201 Interim Data at the European Society for Medical Oncology Congress 2024

WATERTOWN, Mass. and GOSSELIES, Belgium, Aug. 20, 2024 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS) (“iTeos”), a clinical-stage biopharmaceutical company pioneering the discovery...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-4.48	-28	16	17.63	11.22	1997638	13.01866153	CS
4	-6.06	-34.4709897611	17.58	18.01	11.22	832204	14.15042787	CS
12	-3.52	-23.4042553191	15.04	18.13	11.22	477068	14.87027991	CS
26	1.27	12.3902439024	10.25	18.75	10.01	447718	14.96495115	CS
52	-0.74	-6.03588907015	12.26	18.75	8.2	408604	12.80755724	CS
156	-16.49	-58.8718314888	28.01	52.43	8.2	378753	20.04048088	CS
260	-8.18	-41.5228426396	19.7	52.43	8.2	347845	21.67908506	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
GSIWGarden Stage Ltd	$ 5.74 (152.86%)	40.07M
ZEOZeo Energy Corporation	$ 2.3292 (104.32%)	53.49M
TBIOTelesis Bio Inc	$ 2.72 (100.00%)	41.45M
XCURExicure Inc	$ 3.84 (67.69%)	14.14M
GLMDGalmed Pharmaceuticals Ltd	$ 10.36 (50.14%)	29.96M
HAOHaoxi Health Technology Ltd	$ 0.7399 (-75.34%)	6.5M
XCHXCHG Ltd	$ 8.11 (-55.85%)	906.39k
GDHGGolden Heaven Group Holdings Ltd	$ 2.68 (-35.73%)	401.35k
BLMZBloomZ Inc	$ 0.9099 (-33.58%)	502.74k
HOVRNew Horizon Aircraft Ltd	$ 0.504 (-31.98%)	1.79M
NVDANVIDIA Corporation	$ 119.15 (5.10%)	160.94M
SQQQProShares UltraPro Short QQQ	$ 7.66 (-8.81%)	139.04M
MAXNMaxeon Solar Technologies Ltd	$ 0.1053 (15.84%)	74.99M
FRGTFreight Technologies Inc	$ 0.1308 (5.57%)	74.27M
TSLATesla Inc	$ 242.7749 (6.86%)	62.15M